Laurion Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-13,000
Closed -$2.18M 1385
2019
Q2
$2.18M Buy
+13,000
New +$1.8M 0.02% 366
2019
Q1
Sell
-68,900
Closed -$9.21M 1449
2018
Q4
$9.21M Sell
68,900
-145,500
-68% -$23.9M 0.16% 162
2018
Q3
$40.8M Buy
214,400
+186,900
+680% +$34.3M 0.4% 37
2018
Q2
$4.58M Hold
27,500
0.04% 370
2018
Q1
$4.63M Hold
27,500
0.04% 387
2017
Q4
$4.5M Hold
27,500
0.02% 547
2017
Q3
$5.64M Hold
27,500
0.02% 470
2017
Q2
$6.68M Hold
27,500
0.04% 431
2017
Q1
$6.57M Sell
27,500
-260,700
-90% -$60.7M 0.05% 374
2016
Q4
$60.5M Buy
288,200
+38,200
+15% +$7.91M 0.58% 35
2016
Q3
$57.6M Sell
250,000
-22,400
-8% -$5.47M 0.54% 31
2016
Q2
$63M Buy
+272,400
New +$62.8M 0.99% 23
2016
Q1
Sell
-552,500
Closed -$173M 1216
2015
Q4
$173M Buy
552,500
+425,000
+333% +$127M 1.59% 11
2015
Q3
$34.7M Sell
127,500
-10,000
-7% -$3.07M 0.4% 57
2015
Q2
$41.7M Buy
+137,500
New +$41M 0.38% 68

Other funds holding AGN

Laurion Capital Management's AGN Position: Q2 2020 in Review

Laurion Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,163,966 shares — an estimated $206M sold.

Laurion Capital Management first reported a position in AGN in Q3 2014 and held it in 15 quarters. The position peaked at $206M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Laurion Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Laurion Capital Management sold 1,163,966 Allergan plc shares in Q2 2020, an estimated $206M.
  • Laurion Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 15 quarters.
  • Laurion Capital Management's Allergan plc position peaked at $206M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Laurion Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.